Windtree Therapeutics, Inc.
WINT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $3 | $5 | $40 |
| - Cash | $2 | $4 | $6 | $22 |
| + Debt | $2 | $17 | $2 | $18 |
| Enterprise Value | $1 | $15 | $1 | $35 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$20 | -$39 | -$77 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$20 | -$39 | -$68 |
| % Margin | – | – | – | – |
| EPS Diluted | -104.35 | -4,711.54 | -56,011 | -122,924 |
| % Growth | 97.8% | 91.6% | 54.4% | – |
| Operating Cash Flow | -$15 | -$13 | -$19 | -$24 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$15 | -$13 | -$19 | -$24 |